Systemic thrombolysis, catheter-directed thrombolysis (CDT), and percutaneous pharmacomechanical thrombolysis (PPMT) using tissue plasminogen activator (tPA) have been reported. Tenecteplase (TNK) is a genetically engineered form of tPA with slower plasma clearance, greater resistance to plasminogen ...